Toxicology handbook Jason Armstrong, Ovidiu Pascu.

Author/creator Armstrong, Jason
Other author Pascu, Ovidiu.
Format Electronic
Edition4th edition.
Publication InfoChatswood, NSW : Elsevier Australia, [2022]
Descriptionxi, 558 pages : illustrations, maps ; 19 cm
Supplemental ContentFull text available from ClinicalKey Flex
Subjects

Contents ch. 1. Approach to the Poisoned Patient. 1.1 Overview; 1.2 Resuscitation; 1.3 Risk Assessment; 1.4 Supportive Care and Monitoring; 1.5 Investigations; 1.6 Gastrointestinal Decontamination; 1.7 Enhanced Elimination; 1.8 Antidotes; 1.9 Disposition -- ch.2. Specific Considerations. 2.1 Coma; 2.2 Hypotension; 2.3 Seizures; 2.4 Approach to Delirium; 2.5 Serotonin Toxicity; 2.6 Anticholinergic Toxicity; 2.7 Cholinergic Toxicity; 2.8 Neuroleptic Malignant Syndrome; 2.9 Alcohol Use Disorder; 2.10 Amphetamine Use Disorder; 2.11 Opioid Use Disorder; 2.12 Sedative-Hypnotic Use Disorder; 2.13 Solvent Abuse; 2.14 Body Packers and Stuffers; 2.15 Osmolar Gap; 2.16 Acid-Base Disorders; 2.17 The 12-Lead ECG in Toxicology; 2.18 Approach to Mushroom Poisoning; 2.19 Approach to Plant Poisoning; 2.20 Poisoning During Pregnancy and Lactation; 2.21 Poisoning in Children; 2.22 Poisoning in the Elderly -- ch.3. Specific Toxins. 3.1 Alcohol: Ethanol; 3.2 Alcohol: Ethylene Glycol; 3.3 Alcohol: Isopropanol (isopropyl alcohol); 3.4 Alcohol: Methanol (methyl alcohol); 3.5 Alcohol: Other Toxic Alcohols; 3.6 Amisulpride; 3.7 Amphetamines and Amphetamine-Like Substances; 3.8 Angiotensin-Converting Enzyme Inhibitors (ACEIs) and Angiotensin II Receptor Blockers (ARBs); 3.9 Anticoagulant Rodenticides; 3.10 Anticonvulsants: Newer Agents; 3.11 Antihistamines (non-sedating); 3.12 Antihistamines (sedating); 3.13 Arsenic; 3.14 Baclofen; 3.15 Barbiturates; 3.16 Benzodiazepines; 3.17 Benztropine; 3.18 Beta-Blockers; 3.19 Bupropion; 3.20 Button Batteries; 3.21 Calcium Channel Blockers (CCBs); 3.22 Cannabinoids and synthetic cannabinoid receptor agonists (SCRAs); 3.23 Carbamazepine; 3.24 Carbon Monoxide; 3.25 Chloroquine and Hydroxychloroquine; 3.26 Chloral Hydrate; 3.27 Clonidine and other central [alpha]2-adrenergic agonists; 3.28 Clozapine; 3.29 Cocaine; 3.30 Colchicine; 3.31 Corrosives; 3.32 Cyanide; 3.33 Digoxin: Acute Overdose; 3.34 Digoxin: Chronic Poisoning; 3.35 Diphenoxylate-Atropine; 3.36 Direct Oral Anticoagulants; 3.37 Gamma-Hydroxybutyrate (GHB); 3.38 Glyphosate; 3.39 Hydrocarbons; 3.40 Hydrofluoric Acid; 3.41 Hydrogen Peroxide; 3.42 Insulin; 3.43 Iron; 3.44 Isoniazid; 3.45 Lamotrigine; 3.46 Lead; 3.47 Lithium: Acute Overdose; 3.48 Lithium: Chronic Poisoning; 3.49 Local Anaesthetic Agents; 3.50 Mercury; 3.51 Metformin; 3.52 Methotrexate; 3.53 Mirtazapine; 3.54 Monoamine Oxidase Inhibitors (MAOIs); 3.55 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs); 3.56 Olanzapine; 3.57 Opioids; 3.58 Organochlorines; 3.59 Organophosphorus Agents (organophosphates and carbamates); 3.60 Paracetamol: Immediate-Release Preparations (Acute Overdose); 3.61 Paracetamol: Modified-Release Formulations; 3.62 Paracetamol: Repeated Supratherapeutic Ingestion; 3.63 Paraquat; 3.64 Phenothiazines and Butyrophenones (antipsychotic agents); 3.65 Phenytoin; 3.66 Potassium Chloride; 3.67 Pregabalin; 3.68 Quetiapine; 3.69 Quinine; 3.70 Risperidone; 3.71 Salicylates; 3.72 Selective Serotonin Reuptake Inhibitors (SSRIs); 3.73 Strychnine; 3.74 Sulfonylureas; 3.75 Theophylline; 3.76 Thyroxine; 3.77 Tramadol and Tapentadol; 3.78 Tricyclic Antidepressants (TCAs); 3.79 Valproic Acid (sodium valproate); 3.80 Venlafaxine and Desvenlafaxine; 3.81 Warfarin -- ch.4. Antidotes. 4.1 Atropine; 4.2 Calcium; 4.3 Cyproheptadine; 4.4 Desferrioxamine; 4.5 Digoxin Immune Fab; 4.6 Dimercaprol; 4.7 DMSA (Succimer) and DMPS (Unithiol); 4.8 Ethanol; 4.9 Flumazenil; 4.10 Folinic Acid; 4.11 Fomepizole; 4.12 Glucose; 4.13 Hydroxocobalamin; 4.14 Insulin (high-dose); 4.15 Intravenous Lipid Emulsion; 4.16 Methylene Blue; 4.17 N-Acetylcysteine; 4.18 Naloxone; 4.19 Octreotide; 4.20 Penicillamine; 4.21 Physostigmine; 4.22 Pralidoxime; 4.23 Pyridoxine; 4.24 Sodium Bicarbonate; 4.25 Sodium Calcium Edetate; 4.26 Sodium Thiosulfate; 4.27 Vitamin K -- ch.5. Envenomings. 5.1 Approach to Snakebite; 5.2 Black Snake; 5.3 Brown Snake; 5.4 Death Adder; 5.5 Tiger Snake Group; 5.6 Taipan; 5.7 Sea snakes; 5.8 Australian Scorpions; 5.9 Bluebottle Jellyfish (Physalia species); 5.10 Stonefish; 5.11 Box Jellyfish; 5.12 Irukandji Syndrome; 5.13 Blue-Ringed Octopus; 5.14 Redback Spider; 5.15 Funnel-Web (Big Black) Spider; 5.16 White-Tailed Spider; 5.17 Ticks -- ch.6. Antivenoms. 6.1 Black Snake Antivenom; 6.2 Brown Snake Antivenom; 6.3 Death Adder Antivenom; 6.4 Tiger Snake Antivenom; 6.5 Taipan Antivenom; 6.6 Sea Snake Antivenom; 6.7 Polyvalent Snake Antivenom; 6.8 Stonefish Antivenom; 6.9 Box Jellyfish Antivenom; 6.10 Redback Spider Antivenom; 6.11 Funnel-Web Spider Antivenom; 6.12 Allergic Reactions to Antivenom -- Appendices. Appendix 1: Poisons Information Telephone Numbers; Appendix 2: Conversion Factors and Therapeutic Ranges for Important Toxins; Appendix 3: N-Acetylcysteine (NAC) IV Infusion for Paracetamol Poisoning; Appendix 4: Alcohol Withdrawal Score.
General notePreceded by: Toxicology handbook / [edited by] Lindsay Murray, Mark Little, Ovidiu Pascu, Kerry Hoggett. 3rd edition. [2015].
Bibliography noteIncludes bibliographical references and index.
Access restrictionAvailable only to authorized users.
Technical detailsMode of access: World Wide Web
Genre/formElectronic books.
ISBN9780729544368 paperback
ISBN0729544362 paperback

Availability

Library Location Call Number Status Item Actions
Electronic Resources Access Content Online ✔ Available